Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J McCormack

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
The Journal of Laboratory and Clinical Medicine|September 1, 1996
Amplification of antibody production by phosphorothioate oligodeoxynucleotidesR F Branda, A L Moore, A R Lafayette, et al.
Journal of Medicinal Chemistry|October 15, 1993
2,4-Diaminothieno[2,3-d]pyrimidine analogues of trimetrexate and piritrexim as potential inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductaseA Rosowsky, C E Mota, J E Wright, et al.
Annals of Clinical Biochemistry|September 1, 1980
A recommended scheme for the evaluation of kits in the clinical laboratoryI W Percy-Robb, P M Broughton, R D Jennings, et al.
Journal of Medicinal Chemistry|August 1, 1982
Synthesis and antitumor activity of new platinum complexesD B Brown, A R Khokhar, M P Hacker, et al.
Journal of Thrombosis and Haemostasis : JTH|June 30, 2018
Tuning the endothelial response: differential release of exocytic cargos from Weibel-Palade bodiesT D Nightingale, J J McCormack, W Grimes, et al.
Scientific Reports|August 25, 2017
The scaffold protein Ajuba suppresses CdGAP activity in epithelia to maintain stable cell-cell contactsJ J McCormack, S Bruche, A B D Ouadda, et al.
Cancer Treatment Reports|February 1, 1987
Phase I trial of tiazofurin administered by i.v. bolus daily for 5 days, with pharmacokinetic evaluationJ D Roberts, J A Stewart, J J McCormack, et al.
Cancer Research|September 1, 1988
Phase I clinical and pharmacokinetic study of trimetrexate using a daily x5 scheduleJ A Stewart, J J McCormack, W Tong, et al.
Journal of Medicinal Chemistry|June 19, 1998
Inhibition of in vitro and in vivo HIV replication by a distamycin analogue that interferes with chemokine receptor function: a candidate for chemotherapeutic and microbicidal applicationO M Howard, J J Oppenheim, M G Hollingshead, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
The Journal of Laboratory and Clinical Medicine|September 1, 1996
Amplification of antibody production by phosphorothioate oligodeoxynucleotidesR F Branda, A L Moore, A R Lafayette, et al.
Journal of Medicinal Chemistry|October 15, 1993
2,4-Diaminothieno[2,3-d]pyrimidine analogues of trimetrexate and piritrexim as potential inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductaseA Rosowsky, C E Mota, J E Wright, et al.
Annals of Clinical Biochemistry|September 1, 1980
A recommended scheme for the evaluation of kits in the clinical laboratoryI W Percy-Robb, P M Broughton, R D Jennings, et al.
Journal of Medicinal Chemistry|August 1, 1982
Synthesis and antitumor activity of new platinum complexesD B Brown, A R Khokhar, M P Hacker, et al.
Journal of Thrombosis and Haemostasis : JTH|June 30, 2018
Tuning the endothelial response: differential release of exocytic cargos from Weibel-Palade bodiesT D Nightingale, J J McCormack, W Grimes, et al.
Scientific Reports|August 25, 2017
The scaffold protein Ajuba suppresses CdGAP activity in epithelia to maintain stable cell-cell contactsJ J McCormack, S Bruche, A B D Ouadda, et al.
Cancer Treatment Reports|February 1, 1987
Phase I trial of tiazofurin administered by i.v. bolus daily for 5 days, with pharmacokinetic evaluationJ D Roberts, J A Stewart, J J McCormack, et al.
Cancer Research|September 1, 1988
Phase I clinical and pharmacokinetic study of trimetrexate using a daily x5 scheduleJ A Stewart, J J McCormack, W Tong, et al.
Journal of Medicinal Chemistry|June 19, 1998
Inhibition of in vitro and in vivo HIV replication by a distamycin analogue that interferes with chemokine receptor function: a candidate for chemotherapeutic and microbicidal applicationO M Howard, J J Oppenheim, M G Hollingshead, et al.
Pageof 4